Silvan Tuerkcan
Stock Analyst at JMP Securities
(0.98)
# 1952
Out of 5,329 analysts
189
Total ratings
32.48%
Success rate
-4.53%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
FHTX Foghorn Therapeutics | Reiterates: Market Outperform | 9 9 | 4.17 | 115.83% | 2 | Apr 30, 2025 | |
ENGN enGene Holdings | Reiterates: Market Outperform | 18 18 | 3.65 | 393.15% | 4 | Apr 29, 2025 | |
TSHA Taysha Gene Therapie... | Reiterates: Market Outperform | 5 5 | 2.42 | 106.61% | 12 | Apr 28, 2025 | |
NUVB Nuvation Bio | Initiates Coverage On: Market Outperform | 6 | 2.27 | 164.32% | 1 | Apr 23, 2025 | |
TERN Terns Pharma | Reiterates: Market Outperform | 20 20 | 3.56 | 461.8% | 12 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 41 41 | 38.9 | 5.4% | 21 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 18 20 | 14.44 | 38.5% | 11 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 17 17 | 1.36 | 1150% | 5 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 7 7 | 0.34 | 1958.82% | 7 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Perform | n/a | n/a | n/a | 8 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 15 15 | 3.66 | 309.84% | 2 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 10 10 | 1.74 | 474.71% | 2 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 86 86 | 37.73 | 127.94% | 14 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 70 70 | 5.38 | 1201.12% | 5 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Market Outperform | 4 | 0.87 | 359.77% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 21 21 | 3.31 | 534.44% | 10 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 12 12 | 0.67 | 1691.04% | 11 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 12 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 4 | Sep 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 6 6 | 1.61 | 272.67% | 6 | May 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 240 280 | 278.48 | 0.55% | 3 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 9 | Oct 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 18 18 | 11.79 | 52.67% | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 10 | Jan 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 2 3 | 7.07 | -57.57% | 3 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 2 | Oct 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Perform | n/a | n/a | n/a | 3 | Sep 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 200 210 | n/a | n/a | 8 | Jun 30, 2020 |